Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Roche wins FDA approval for blood screening test
The test, called the cobas TaqScreen MPX Test for use on the cobas s 201 system, is a vitro test for comprehensive single-assay detection of HIV-1 group M
The test, called the cobas TaqScreen MPX Test for use on the cobas s 201 system, is a vitro test for comprehensive single-assay detection of HIV-1 group M
Akorn-Strides is a joint venture that was formed in 2004 by Akorn and Strides Arcolab. The primary mission for the joint venture is to develop liquid, lyophilized and
Ryzolt is indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time.
CytoCare is an automated robotic system for the safe preparation of hazardous patient-specific IV medications. Originally developed for cancer therapy, CytoCare has also been proven to compound monoclonal antibodies
Based on its review, the FDA has determined that the application cannot be approved in its present form and that clinical data from an additional adequate and well-controlled
The management believes that it is in the best interest of the company to focus its resources on the company’s advanced in-vitro diagnostic (IVD) operations which provide recurring
Stryker Endoscopy’s WiSe high-definition (HD) TV is embedded with Amimon’s wireless HD technology. Amimon has granted Stryker Endoscopy exclusive access to its technology for the medical endoscopy market.
In accordance with the letter of intent signed in October 2008, the closing of the proposed business combination was subject to certain terms and conditions, including obtaining necessary
MelaFind features a hand-held imaging device that emits light of multiple wavelengths to capture images of suspicious pigmented skin lesions and extract data. Using sophisticated algorithms, the data
CytoCare is claimed to be the world’s first and only automated robotic system for the safe preparation of hazardous patient-specific IV medications. Originally developed for cancer therapy, CytoCare